STEPHANIE BARONE: Open Payments
NPI 1518603513 · SPENCERPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,410 in 101 payments from 20 companies in 2025. Trend: 2023 $2,852 · 2024 $2,459 · 2025 $3,410
Food & beverage: $3,410
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $697 |
| Amgen Inc. | 17 | $409 |
| AstraZeneca Pharmaceuticals LP | 14 | $401 |
| Novo Nordisk Inc | 7 | $339 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $242 |
| Axsome Therapeutics, Inc. | 6 | $221 |
| Phathom Pharmaceuticals, Inc. | 4 | $168 |
| Abbott Laboratories | 3 | $161 |
| Verona Pharma, Inc. | 3 | $158 |
| Lundbeck LLC | 5 | $131 |
Products named: Ozempic, QULIPTA, OTEZLA, REXULTI, Kerendia, Auvelity, UBRELVY, VRAYLAR.
Industry payments across NY — which companies pay providers there.
